HER2-targeted Therapy for Salivary Gland Cancer
Salivary gland cancer is rare, and there are no standard treatments for advanced-stage disease. Recent research supports the use...
Salivary gland cancer is rare, and there are no standard treatments for advanced-stage disease. Recent research supports the use...
In April 2026, AACR's journals editors highlighted studies on cancer survivors taking GLP-1 agonists, an immunotherapy-boosting bacteria, and more.
Injecting immunotherapy directly into precancerous oral lesions may be an effective way to prevent progression to cancer without surgery.
In February, the editors of AACR's journals highlighted studies on the FDA’s accelerated approval pathway, how metabolism impacts prostate...
The countdown to the new year is nearly upon us, but no need to count down to the last...
In November, the AACR’s journal editors highlighted studies on sucralose limiting immunotherapy, benefits of caloric restriction, and more.
New research is redefining the role of surgery, revealing approaches to help cancer patients preserve their organs, function, and...
For August 2025, the editors of AACR's journals highlighted studies on liquid biopsy for brain cancer, new treatment strategies...
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
Adding pembrolizumab before and after surgery to standard of care improved outcomes in patients with previously untreated head and...